Table 1.
Common Treatment Regimens in the United States for Tularemia and Treatment-Related Complications in Pregnancy
| Antibiotic | Pregnancy Category | Category Interpretation (From US FDA) | Distribution | Treatment Complications |
|---|---|---|---|---|
| Gentamicin | Category D | Evidence of risk | Crosses the placenta | Congenital deafness |
| Doxycycline | Category D | Evidence of risk | Crosses the placenta | Possible discoloration of teeth and enamel hypoplasia |
| Ciprofloxacin | Category C | Risk cannot be ruled out | Crosses the placenta | Teratogenicity observed in animal models, not observed in limited human studies |
| Levofloxacin | Category C | Risk cannot be ruled out | Crosses the placenta | Teratogenicity observed in animal models, not observed in limited human studies |
| Azithromycin | Category B | No evidence of risk in studies | Crosses the placenta |
Abbreviation: FDA, Food and Drug Administration.